Louisiana State Employees Retirement System’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-42,700
| Closed | -$263K | – | 1537 |
|
|
2025
Q4 | $263K | Sell |
42,700
-100
| -0.2% | -$725 | ﹤0.01% | 1484 |
|
|
2025
Q3 | $309K | Sell |
42,800
-300
| -0.7% | -$1.78K | 0.01% | 1457 |
|
|
2025
Q2 | $229K | Buy |
43,100
+200
| +0.5% | +$1.18K | ﹤0.01% | 1500 |
|
|
2025
Q1 | $381K | Sell |
42,900
-1,100
| -3% | -$13.2K | 0.01% | 1409 |
|
|
2024
Q4 | $603K | Buy |
44,000
+100
| +0.2% | +$1.84K | 0.01% | 1275 |
|
|
2024
Q3 | $1.2M | Sell |
43,900
-1,600
| -4% | -$43.3K | 0.02% | 898 |
|
|
2024
Q2 | $1.11M | Buy |
45,500
+1,700
| +4% | +$37.3K | 0.02% | 870 |
|
|
2024
Q1 | $934K | Sell |
43,800
-600
| -1% | -$12.9K | 0.02% | 1028 |
|
|
2023
Q4 | $850K | Buy |
44,400
+2,700
| +6% | +$46.7K | 0.02% | 1082 |
|
|
2023
Q3 | $669K | Sell |
41,700
-1,100
| -3% | -$20.9K | 0.02% | 1153 |
|
|
2023
Q2 | $992K | Buy |
42,800
+5,000
| +13% | +$109K | 0.02% | 896 |
|
|
2023
Q1 | $878K | Sell |
37,800
-700
| -2% | -$14.2K | 0.02% | 906 |
|
|
2022
Q4 | $559K | Hold |
38,500
| – | – | 0.02% | 1179 |
|
|
2022
Q3 | $735K | Sell |
38,500
-300
| -0.8% | -$6.88K | 0.02% | 938 |
|
|
2022
Q2 | $883K | Hold |
38,800
| – | – | 0.02% | 892 |
|
|
2022
Q1 | $891K | Buy |
38,800
+100
| +0.3% | +$2.56K | 0.02% | 966 |
|
|
2021
Q4 | $1.07M | Buy |
38,700
+1,100
| +3% | +$31.9K | 0.02% | 874 |
|
|
2021
Q3 | $1.21M | Buy |
37,600
+2,900
| +8% | +$96.3K | 0.03% | 728 |
|
|
2021
Q2 | $1.06M | Buy |
34,700
+500
| +1% | +$14.4K | 0.03% | 840 |
|
|
2021
Q1 | $1.04M | Sell |
34,200
-400
| -1% | -$11.4K | 0.03% | 832 |
|
|
2020
Q4 | $684K | Hold |
34,600
| – | – | 0.02% | 1000 |
|
|
2020
Q3 | $451K | Buy |
34,600
+14,330
| +71% | +$181K | 0.02% | 1035 |
|
|
2020
Q2 | $230K | Sell |
20,270
-300
| -1% | -$4.26K | 0.01% | 1172 |
|
|
2020
Q1 | $294K | Sell |
20,570
-4,940
| -19% | -$104K | 0.02% | 940 |
|
|
2019
Q4 | $695K | Sell |
25,510
-1,790
| -7% | -$49.2K | 0.03% | 756 |
|
|
2019
Q3 | $782K | Sell |
27,300
-100
| -0.4% | -$2.91K | 0.04% | 662 |
|
|
2019
Q2 | $705K | Hold |
27,400
| – | – | 0.04% | 755 |
|
|
2019
Q1 | $910K | Sell |
27,400
-677
| -2% | -$20.6K | 0.05% | 584 |
|
|
2018
Q4 | $816K | Sell |
28,077
-3,223
| -10% | -$116K | 0.05% | 568 |
|
|
2018
Q3 | $1.44M | Hold |
31,300
| – | – | 0.06% | 363 |
|
|
2018
Q2 | $1.17M | Buy |
31,300
+300
| +1% | +$10.1K | 0.05% | 489 |
|
|
2018
Q1 | $916K | Buy |
31,000
+1,200
| +4% | +$40.6K | 0.04% | 638 |
|
|
2017
Q4 | $1.02M | Buy |
29,800
+2,100
| +8% | +$70.8K | 0.05% | 551 |
|
|
2017
Q3 | $1M | Hold |
27,700
| – | – | 0.05% | 553 |
|
|
2017
Q2 | $716K | Hold |
27,700
| – | – | 0.04% | 784 |
|
|
2017
Q1 | $532K | Buy |
+27,700
| New | +$491K | 0.03% | 997 |
|
Other funds holding MYGN
Louisiana State Employees Retirement System's MYGN Position: Q1 2026 in Review
Louisiana State Employees Retirement System sold out of Myriad Genetics (MYGN) in Q1 2026, closing a stake of 42,700 shares — an estimated $263K sold.
Louisiana State Employees Retirement System first reported a position in MYGN in Q1 2017 and held it in 36 quarters. The position peaked at $1.44M in Q3 2018. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Louisiana State Employees Retirement System reported no remaining Myriad Genetics position as of Q1 2026 after selling out during the quarter.
- Louisiana State Employees Retirement System sold 42,700 Myriad Genetics shares in Q1 2026, an estimated $263K.
- Louisiana State Employees Retirement System first reported a position in Myriad Genetics in Q1 2017 and held it in 36 quarters.
- Louisiana State Employees Retirement System's Myriad Genetics position peaked at $1.44M in Q3 2018.
- 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Louisiana State Employees Retirement System's 13F filing for Q1 2026, filed 20 Apr 2026.